Literature DB >> 35241831

Exploiting senescence for the treatment of cancer.

Liqin Wang1, Lina Lankhorst2, René Bernards3.   

Abstract

Senescence is a cellular response to a variety of stress signals that is characterized by a stable withdrawal from the cell cycle and major changes in cell morphology and physiology. While most research on senescence has been performed on non-cancer cells, it is evident that cancer cells can also mount a senescence response. In this Review, we discuss how senescence can be induced in cancer cells. We describe the distinctive features of senescent cancer cells and how these changes in cellular physiology might be exploited for the selective eradication of these cells (senolysis). We discuss activation of the host immune system as a particularly attractive way to clear senescent cancer cells. Finally, we consider the challenges and opportunities provided by a 'one-two punch' sequential treatment of cancer with pro-senescence therapy followed by senolytic therapy.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35241831     DOI: 10.1038/s41568-022-00450-9

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   69.800


  234 in total

1.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

2.  Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation.

Authors:  Marzia Fumagalli; Francesca Rossiello; Michela Clerici; Sara Barozzi; Davide Cittaro; Jessica M Kaplunov; Gabriele Bucci; Miryana Dobreva; Valentina Matti; Christian M Beausejour; Utz Herbig; Maria Pia Longhese; Fabrizio d'Adda di Fagagna
Journal:  Nat Cell Biol       Date:  2012-03-18       Impact factor: 28.824

3.  Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.

Authors:  B D Chang; Y Xuan; E V Broude; H Zhu; B Schott; J Fang; I B Roninson
Journal:  Oncogene       Date:  1999-08-26       Impact factor: 9.867

4.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  Virus-induced senescence is a driver and therapeutic target in COVID-19.

Authors:  Soyoung Lee; Yong Yu; Jakob Trimpert; Fahad Benthani; Mario Mairhofer; Paulina Richter-Pechanska; Emanuel Wyler; Dimitri Belenki; Sabine Kaltenbrunner; Maria Pammer; Lea Kausche; Theresa C Firsching; Kristina Dietert; Michael Schotsaert; Carles Martínez-Romero; Gagandeep Singh; Séverine Kunz; Daniela Niemeyer; Riad Ghanem; Helmut J F Salzer; Christian Paar; Michael Mülleder; Melissa Uccellini; Edward G Michaelis; Amjad Khan; Andrea Lau; Martin Schönlein; Anna Habringer; Josef Tomasits; Julia M Adler; Susanne Kimeswenger; Achim D Gruber; Wolfram Hoetzenecker; Herta Steinkellner; Bettina Purfürst; Reinhard Motz; Francesco Di Pierro; Bernd Lamprecht; Nikolaus Osterrieder; Markus Landthaler; Christian Drosten; Adolfo García-Sastre; Rupert Langer; Markus Ralser; Roland Eils; Maurice Reimann; Dorothy N Y Fan; Clemens A Schmitt
Journal:  Nature       Date:  2021-09-13       Impact factor: 69.504

Review 6.  Role of telomeres and telomerase in genomic instability, senescence and cancer.

Authors:  Yibin Deng; Sandy Chang
Journal:  Lab Invest       Date:  2007-09-03       Impact factor: 5.662

7.  Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.

Authors:  Jan R Dörr; Yong Yu; Maja Milanovic; Gregor Beuster; Christin Zasada; J Henry M Däbritz; Jan Lisec; Dido Lenze; Anne Gerhardt; Katharina Schleicher; Susanne Kratzat; Bettina Purfürst; Stefan Walenta; Wolfgang Mueller-Klieser; Markus Gräler; Michael Hummel; Ulrich Keller; Andreas K Buck; Bernd Dörken; Lothar Willmitzer; Maurice Reimann; Stefan Kempa; Soyoung Lee; Clemens A Schmitt
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

8.  Mitochondrial dysfunction contributes to oncogene-induced senescence.

Authors:  Olga Moiseeva; Véronique Bourdeau; Antoine Roux; Xavier Deschênes-Simard; Gerardo Ferbeyre
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

9.  Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing.

Authors:  Bernadette Carroll; Glyn Nelson; Yoana Rabanal-Ruiz; Olena Kucheryavenko; Natasha A Dunhill-Turner; Charlotte C Chesterman; Qabil Zahari; Tong Zhang; Sarah E Conduit; Christina A Mitchell; Oliver D K Maddocks; Penny Lovat; Thomas von Zglinicki; Viktor I Korolchuk
Journal:  J Cell Biol       Date:  2017-05-31       Impact factor: 10.539

Review 10.  Cellular senescence as a potential mediator of COVID-19 severity in the elderly.

Authors:  Jamil Nehme; Michela Borghesan; Sebastian Mackedenski; Thomas G Bird; Marco Demaria
Journal:  Aging Cell       Date:  2020-09-21       Impact factor: 9.304

View more
  16 in total

1.  Senescent Tumor Cells in the Peritoneal Carcinomatosis Drive Immunosenescence in the Tumor Microenvironment.

Authors:  Heidi Braumüller; Bernhard Mauerer; Christopher Berlin; Dorothea Plundrich; Patrick Marbach; Pierre Cauchy; Claudia Laessle; Esther Biesel; Philipp Anton Holzner; Rebecca Kesselring
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 2.  Interplay between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy.

Authors:  Luke V Loftus; Sarah R Amend; Kenneth J Pienta
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

Review 3.  Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer.

Authors:  Ioanna Mourkioti; Andriani Angelopoulou; Konstantinos Belogiannis; Nefeli Lagopati; Spyridon Potamianos; Efthymios Kyrodimos; Vassilis Gorgoulis; Angelos Papaspyropoulos
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

4.  Exploring the Relationship Between Senescence and Colorectal Cancer in Prognosis, Immunity, and Treatment.

Authors:  Kechen Dong; Jianping Liu; Wei Zhou; Guanglin Zhang
Journal:  Front Genet       Date:  2022-06-15       Impact factor: 4.772

5.  Specific Irreversible Cell-Cycle Arrest and Depletion of Cancer Cells Obtained by Combining Curcumin and the Flavonoids Quercetin and Fisetin.

Authors:  Viviana Barra; Roberta Flavia Chiavetta; Simona Titoli; Ivana Maria Provenzano; Pietro Salvatore Carollo; Aldo Di Leonardo
Journal:  Genes (Basel)       Date:  2022-06-23       Impact factor: 4.141

6.  Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer.

Authors:  Longfei Dai; Xu Wang; Tao Bai; Jianjun Liu; Bo Chen; Ting Li; Wenqi Yang
Journal:  Front Genet       Date:  2022-08-04       Impact factor: 4.772

7.  A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.

Authors:  Jian-Xuan Sun; Chen-Qian Liu; Jin-Zhou Xu; Ye An; Meng-Yao Xu; Xing-Yu Zhong; Na Zeng; Si-Yang Ma; Hao-Dong He; Zong-Biao Zhang; Shao-Gang Wang; Qi-Dong Xia
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 8.  Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer.

Authors:  Francesco Melia; Palita Udomjarumanee; Dmitry Zinovkin; Nahid Arghiani; Md Zahidul Islam Pranjol
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

Review 9.  Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A.

Authors:  Chao Yang; Dan Li; Shaohong Zang; Lei Zhang; Zhangfeng Zhong; Yingtang Zhou
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

10.  Nutritional Niches of Cancer Therapy-Induced Senescent Cells.

Authors:  Àngela Llop-Hernández; Sara Verdura; Elisabet Cuyàs; Javier A Menendez
Journal:  Nutrients       Date:  2022-09-02       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.